Area of research
Neurology · Molecular Biology
Research interest
Research interests include Neuroblastoma Research and Treatments, Cancer, Hypoxia, and Metabolism, Receptor Mechanisms and Signaling, and Ubiquitin and proteasome pathways.
Kit-mediated autophagy suppression driven by a viral oncoprotein emerges as a crucial survival mechanism in Merkel cell carcinoma
The multiple functions of miR-574-5p in the neuroblastoma tumor microenvironment
PPM1D is a neuroblastoma oncogene and therapeutic target in childhood neural tumors
Neuroblastoma—A Neural Crest Derived Embryonal Malignancy
Inhibition of Rho-Associated Kinase Suppresses Medulloblastoma Growth
Molecular mechanisms and therapeutic targets in neuroblastoma
Melflufen - a peptidase-potentiated alkylating agent in clinical trials
Rho-associated kinase is a therapeutic target in neuroblastoma
Establishment and characterization of an orthotopic patient-derived Group 3 medulloblastoma model for preclinical drug evaluation
Wnt/β-catenin pathway regulates MGMT gene expression in cancer and inhibition of Wnt signalling prevents chemoresistance
Abstract A84: Stereotactic injections of primary medulloblastomas as a representative model of the different subgroups for preclinical drug screening
Abstract 2751: Wnt/β-catenin regulates the expression of MGMT through TCF/LEF transcription: new strategy for DNA alkylators in cancer therapy.
Targeting the hedgehog signal transduction pathway at the level of GLI inhibits neuroblastoma cell growth <i>in vitro</i> and <i>in vivo</i>